type full_text Clinical Summary 87 Years old femaleDA to Paracetamol NH resident PMH 1. Dementia with Lewy body Previously dx AD with BPSD, has auditory and visual hallucinations of children and people 13/8/21: AMT 6/10 CMMSE 13/28 On Rivastigmine, Fluvoxamine and Valproate On Clonazepam 2. TIA seen in SGH [REDACTED_NUMBER]. HTN 4. HLD 5. AF with presumptive tachy induced CMP On Rivaroxaban MIBI (Oct 2019): Neg for ischemia. EF 61 on MIBI Last TTE (June 2021): EF 50 55 6. Impaired fasting glucose 7. Hep B carrier 8. Osteoporosis with L 2/ L 4 compression BMD (2017): T score left femoral neck 4.1, left hip 3.7, lumbar spine 3.0 On Alendronate 9. Unwitnessed fall cx by minimally displaced right superior pubic rami fracture, T 7,L 2 and L 4 compression fracture, long lie, bruise right frontal area, bruise right knee, scalp hematoma Conservative Mx 10. Mild OAB 11. Bilateral cataracts 12. Likely Pulmonary Malignancy family not keen for further follow uplast adm Dec 2022:1. Desaturation 2' pneumonia HOPCFrom SCDF:during evening rounds at NH, pt noted to be SOB and chestySOB 58 on RAsuction large amount whitish phlegmon arrival of SCDF, spo2 ~70 s > 95 on NPHR 181 T 38.4 allergic to paracetamolNoted EOC DNR Maxward from Dec 2022 admissions/t Mr [REDACTED] [REDACTED] [REDACTED][REDACTED] phone explained and updated him regarding admissionhe is aware from ED doctors that she is very illexplained could be due to pneumonia already on maximal amount of oxygen that we can give revisited discussion on EOCMr Wong mentioned that her baseline is already very poor and not communicative they would like to keep her comfortable and not see her suffer explained that that is completely understandableexplained that she is critically ill and family should come and see her as soon as possible they are aware and are rushing down O/ETmax 38.4 BP 157/73 HR 114 RR 23 SpO2 92 on NRM eyes open but not communicative Lungs rhonchiAbdomen soft, non tender no guarding Calves supple bedside US by ED IVC collapseProgress in EDIV HM 1.5 L IV AugmentinInitial IxNa 132 CRP 16.6 Procal flat TW 13.5 Neut 10.4 Issues 1. Pneumonia with possible aspiration component complicated by likely concomitant HAP TW 14.6 > 14.7 CRP 16.6, procal flat CXR 1/5 Known right perihilar mass show interval size progression. Background emphysematous changes are seen. There is no large pleural effusion, consolidation, pneumothorax or subdiaphragmatic air is seen. Old healed fracture of left lower rib noted. Nodular density projected over the right supraclavicular fossae worrisome for the nodal mass. Resp swab negative Blood cs (1/5) NBG x 48 h given IV Tazo x 5/7, oralised to PO augmentin to complete 1 week IV furosemide 40 mg given once however, desaturated to 90 on 6/5, escalated back to IV tazocin CXR 6/5 Tip of the feeding tube is projecting over the expected region of the stomach.Grossly stable right hilar mass is again noted.Patchy air space opacities are noted in right mid and lower zones, suspicious for infective changes.Blunting of bilateral costophrenic angles could be due to small pleural effusions.Old healed left lower rib fracture is again noted. oralised back to PO augmentin to complete 1 week Abx from 6/5 PO furosemide 20 mg given once CXR repeated on 11/5 prior to discharge > noted overall improvementComplicated by fast AF Trops 101 > 90 > 59 (2/5) > 38 (7/5) Increased digoxin to 125 mcg OM (4/5) > digoxin level 0.8 on increased dose > HR stable on digoxin 125 mcg OM <Antibiotics> s/p IV Tazo (1/5 5/5) s/p PO Augmentin (5/5 6/5) s/p D 4 IV Tazocin (6/5 9/5)Oralised to PO Augmentin (10/5 12/5)2. Presumptive COPD noted transient desaturation last admission in Sep 22 CXR NAD clinically lungs clear, no wheeze or rhonchi impression: transient desaturation 2' underlying emphysema also noted severe emphysema seen on CTPA done in Sep 2022 started Spiolto and PRN Salbutamol with spacer mask SpO2 targets 92 94 3. Occasional high random blood glucose readings HbA1c 6.7 Glu 10.6, 11.3 advised for CBG monitoring in NH TCU OPS for DM control Patient was transferred back to NH well and stable on 11/5/23. <Medication changes> Increased digoxin to 125 mcg OM (4/5) digoxin level 0.8 on increased dose <Discharge Plan> TCU OPS 4 6 weeks to repeat CXR ivo patchy air space opacities Memo to NH regarding SpO2 targets 92 94 Care Plan TCU OPS 4 6 weeks to repeat CXR ivo patchy air space opacities and for DM monitoringMemo to NH regarding SpO2 targets 92 94 and CBG monitoring